Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 1;107(12):e370-e372.
doi: 10.1097/TP.0000000000004843. Epub 2023 Oct 30.

Letter to the Editor: Immunogenicity After the Third Dose of COVID-19 Vaccine in Cardiac Transplantation

Affiliations

Letter to the Editor: Immunogenicity After the Third Dose of COVID-19 Vaccine in Cardiac Transplantation

Afsana Rahman et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding or conflicts of interest.

Figures

FIGURE 1.
FIGURE 1.
De novo DSA pre and post third COVAX dose. The figure shows trend in DSA MFI in individual participants pre and post the third dose of COVAX. Six participants are represented. Dotted black line shows MFI threshold of 1000, which was used as the threshold for de novo DSA development in this study. Development of COVID infection after the third dose of COVAX is marked. Dotted lines mark participants who missed 1 surveillance time point and whose MFI rose out of range. COVAX, COVID-19 vaccination; DSA, donor-specific antibodies; MFI, mean fluorescent intensity.

References

    1. Cordero E, Bulnes-Ramos A, Aguilar-Guisado M, et al. . Effect of influenza vaccination inducing antibody mediated rejection in solid organ transplant recipients. Front Immunol. 2020;11:1917. - PMC - PubMed
    1. Tran A, Fixler D, Huang R, et al. . Donor-specific HLA alloantibodies: impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation. J Heart Lung Transplant. 2016;35:87–91. - PubMed
    1. Centers for Disease Control and Prevention. Covid-19 vaccines for people who are moderately or severely immunocompromised. 2023. Available at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immun.... Accessed June 20, 2023.
    1. McCune TR, Bray RA, Baran DA, et al. . Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients. Transpl Immunol. 2022;75:101722. - PMC - PubMed
    1. Al Jurdi A, Gassen RB, Borges TJ, et al. . Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients. Kidney Int. 2022;101:1282–1286. - PMC - PubMed